TS Financial Group (TSFG)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

TS Financial Group (TSFG)’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-750	Closed	-$87K	–	1083
2023 Q3	$87K	Hold	750	–	–	0.03%	217
2023 Q2	$77K	Hold	750	–	–	0.03%	225
2023 Q1	$82K	Hold	750	–	–	0.03%	218
2022 Q4	$85K	Hold	750	–	–	0.03%	213
2022 Q3	$46K	Hold	750	–	–	0.02%	284
2022 Q2	$60K	Hold	750	–	–	0.03%	260
2022 Q1	$79K	Hold	750	–	–	0.03%	244
2021 Q4	$81K	Hold	750	–	–	0.03%	248
2021 Q3	$82K	Hold	750	–	–	0.03%	249
2021 Q2	$70K	Hold	750	–	–	0.03%	270
2021 Q1	$69K	Hold	750	–	–	0.04%	227
2020 Q4	$55K	Buy	750 +250	+50%	+$18.6K	0.03%	243
2020 Q3	$39K	Hold	500	–	–	0.02%	255
2020 Q2	$28K	Sell	500 -7,000	-93%	-$299K	0.02%	284
2020 Q1	$222K	Hold	7,500	–	–	0.2%	76
2019 Q4	$272K	Hold	7,500	–	–	0.2%	74
2019 Q3	$204K	Hold	7,500	–	–	0.16%	85
2019 Q2	$180K	Hold	7,500	–	–	0.14%	92
2019 Q1	$198K	Buy	+7,500	New	+$178K	0.17%	82

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TS Financial Group (TSFG)'s HZNP Position: Q4 2023 in Review

TS Financial Group (TSFG) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 750 shares — an estimated $87K sold.

TS Financial Group (TSFG) first reported a position in HZNP in Q1 2019 and held it in 19 quarters. The position peaked at $272K in Q4 2019. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

TS Financial Group (TSFG) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
TS Financial Group (TSFG) sold 750 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $87K.
TS Financial Group (TSFG) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 19 quarters.
TS Financial Group (TSFG)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $272K in Q4 2019.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on TS Financial Group (TSFG)'s 13F filing for Q4 2023, filed 24 Jan 2024.